drugset / Trial / NCT00676832
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether COLAL-PRED is a safe and effective treatment for patients with moderate to severe ulcerative colitis.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COLAL-PRED | Unknown | 40 mg | Oral |
| Subject | COLAL-PRED | Unknown | 60 mg | Oral |
| Subject | COLAL-PRED | Unknown | 80 mg | Oral |
| Subject | COLAL-PRED | Unknown | 120 mg | Oral |